The OU Health Stephenson Cancer Center has joined Caris Life Sciences’ (Caris) Precision Oncology Alliance (POA), an extensive network of cancer centres worldwide.

These cancer institutions have partnered for advancing precision oncology and biomarker-driven research.

The members of POA work together for establishing and optimising the standards of care for molecular testing through innovative research that is focused on identifying predictive and prognostic markers which help in improving the clinical outcomes for cancer patients.

The alliance includes 70 cancer centres and academic institutions, which have early access to the extensive database and artificial intelligence platform in Caris.

This will help in establishing the evidence-based standards for cancer profiling and molecular testing in oncology.

Stephenson Cancer Center, located on the University of Oklahoma Health Sciences Center campus in Oklahoma City, is the state’s only National Cancer Institute (NCI)-Designated Cancer Center.

It provides a critical resource for patients who are looking for patient-centred, research-driven, multidisciplinary treatment.

The facility is committed to reduce the adverse effects of cancer as well as its significant impact on underserved areas in Oklahoma.

Caris POA chairman Chadi Nabhan said: “We are excited to welcome OU Health Stephenson Cancer Center to the growing Precision Oncology Alliance network.

“The ability to collaborate with Stephenson Cancer Center clinicians and researchers in cutting edge precision oncology research is destined to help improve the outcomes of patients with cancer and is aligned with both organisations’ vision.”

Stephenson Cancer Center’s dedicated cancer research programmes support 135 investigators who study basic, clinical, and behavioural sciences that are related to cancer care.